NPR News Now - NPR News: 08-07-2025 5PM EDT
Episode Date: August 7, 2025NPR News: 08-07-2025 5PM EDTLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy...
Transcript
Discussion (0)
Live from NPR News, I'm Janine Hurst.
In Miami, a federal judge has issued an order temporarily halting construction at an immigration center in Florida's Everglades.
MPIRS Greg Allen reports the judge says the installation of lighting, paving, and other building on the site has to stop
while she hears a challenge to the facility brought by environmental groups.
Environmental groups and the Miccosuki tribes say construction of the facility dubbed alligator alcatraz by officials
without public input or an environmental impact statement violates federal law.
Lawyers for Florida and the Trump administration said because the facility was built and is operated by the state,
the federal law doesn't apply.
U.S. District Judge Kathleen Williams was unconvinced by that argument.
After two days of hearings, she became frustrated when she learned construction was still going on at the site,
and lawyers for Florida refused a request to put it on hold.
Judge Williams issued a temporary restraining order that stops construction activities for the next 14 days.
Immigration detentions and other operations are unaffected.
Greg Allen, NPR News, Miami.
Vice President Vance met with Indiana Governor Mike Braun
and Republican state legislative lawmakers today
about redrawing the state's congressional district lines
to benefit the GOP.
Indiana Public Broadcasting's Brandon Smith reports.
Democrats rallied at the State House
railing against what they called a moral violation of democracy.
Governor Braun says he and state legislative leaders
listened to what the vice president had to say about redistricting, but wouldn't say more than that.
Democratic Congressman Frank Mervan, one of the lawmakers who could lose his seat,
called on state GOP leaders not to, quote, bend a knee.
And no matter what district they put me in, I will fight for working class people.
In statements, both the state house and Senate Republican leaders said they appreciated meeting with Vance,
but neither made any commitments about redistricting.
For NPR news, I'm Brandon Smith in Indianapolis.
Japan's Prime Minister insists his country is on the same page with the U.S. on tariffs that took effect today.
But as NPR's Anthony Kuhn reports, at the same time, Japan's government is insisting that the U.S. change its directive on the tariffs.
Prime Minister Shigeru Ishiba said Japan has confirmed with the U.S.
that there's no difference in understanding about the 15% tariff rate the two sides agreed on last month.
Japan thought the agreement was that tariffs on its exports would be capped at 15%.
But the U.S. Federal Register says that the 15% is in addition to existing tariffs.
Prime Minister Ishiaba added that Japan is strongly urging the U.S. to change President Trump's
executive order, which took effect today.
This week in Japan's parliament, opposition lawmakers grilled Ishiaba about why he didn't
get the deal with the U.S. in writing.
Ishiaba argued that doing so would have delayed the reduction of the tariffs from the threatened
25% to 15%.
Anthony Kuhn in PR News, Seoul.
Listening to NPR News from Washington.
President Trump says he's instructed the Commerce Department to change how the Census Bureau collects data.
On social media, Trump says his new census would exclude millions of immigrants living in the U.S. without legal status.
It's an unprecedented change to how the country has conducted population tallies since the first census in 1790.
This says preparations for the 2030 census are already underwent.
way. Trump pushed similar efforts in his first administration that sparked legal battles going to the
Supreme Court, which stopped a question about U.S. citizenship status from being added to the 2020 census.
But the High Court, rather, declined to rule on whether a president can exclude people without legal
status from the census. An obesity drug is on the horizon. A study of Eli Lilly's experimental pill
shows patients lost weight, but the results still felt.
short of Wall Street's expectations and shares close down 14%.
If you're Sidney Lubkin reports.
Eli Lilly is testing its new obesity drug pill, or for Glypron, and hopes to begin selling
it next year.
The company announced results of a clinical trial of more than 3,000 people taking
the pill for more than a year.
Patients taking the highest dose lost an average of 27 pounds or 12% of their body weight.
Eli Lilly says side effects included nausea, constipation, and diarrhea.
The company says it plans to submit the once daily pill to the Food and Drug Administration for a review by the end of the year.
Sydney Lupkin, NPR News.
And I'm Janine Hirst, and you're listening to NPR News from Washington.
